NTII OTC
Neurobiological Technologies, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -98.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$16M
+20.6% ▲
Capital Expenditures
$2K
+81.8% ▲
5Y CAGR: -16.6%
Free Cash Flow
-$16M
+20.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$20M
-188.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2004 | FY2005 | FY2006 | FY2007 | FY2008 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$25M | -$28M | -$14M | -$16M | $3M |
| Depreciation & Amort. | $100K | $194K | $230K | $205K | $132K |
| Stock-Based Comp. | $0 | $0 | $0 | $1M | $625K |
| Change in Working Capital | $3M | $24M | $765K | -$6M | -$22M |
| Other Non-Cash Items | $13M | $12M | -$21K | $736K | $1M |
| Operating Cash Flow | -$9M | $9M | -$13M | -$21M | -$16M |
| — Investing Activities — | |||||
| Capital Expenditures | -$645K | -$350K | -$66K | -$11K | -$2K |
| Acquisitions (Net) | -$3M | -$2M | $0 | $0 | $0 |
| Investment Purchases | -$80M | -$91M | -$52M | -$23M | -$42M |
| Investment Sales | $91M | $93M | $54M | $11M | $39M |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $8M | -$199K | $2M | -$12M | -$3M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | -$6M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $42K | $1K |
| Financing Cash Flow | $703K | $106K | $7M | $55M | $1K |
| Net Change in Cash | -$1M | $9M | -$4M | $22M | -$20M |
| Cash End of Period | $828K | $10M | $6M | $28M | $8M |
| Free Cash Flow | -$10M | $9M | -$13M | -$21M | -$16M |